EMA recommendation to suspend HES is hazardous

Lancet. 2018 Feb 24;391(10122):736-738. doi: 10.1016/S0140-6736(18)30254-X. Epub 2018 Feb 12.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Recalls*
  • Europe
  • Humans
  • Hydroxyethyl Starch Derivatives / adverse effects*
  • Plasma Substitutes / adverse effects*

Substances

  • Hydroxyethyl Starch Derivatives
  • Plasma Substitutes